Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$0.11 and traded as low as C$0.10. Resverlogix shares last traded at C$0.10, with a volume of 2,144 shares traded.
Resverlogix Trading Up 5.3%
The business’s 50 day moving average price is C$0.11 and its two-hundred day moving average price is C$0.11. The company has a market capitalization of C$31.62 million, a price-to-earnings ratio of -3.33 and a beta of 0.70. The company has a debt-to-equity ratio of -81.94, a quick ratio of 0.04 and a current ratio of 0.04.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Further Reading
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
